Haryana, India

Mallinath Harwalkar

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Sentiss Pharma Private Limited. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mallinath Harwalkar: Innovator in Ophthalmic Solutions

Introduction

Mallinath Harwalkar is a notable inventor based in Haryana, India. He has made significant contributions to the field of ophthalmic compositions, particularly through his innovative sterilization processes. His work is characterized by a commitment to improving the safety and efficacy of pharmaceutical solutions.

Latest Patents

Mallinath Harwalkar holds a patent for a sterilization process of timolol gel forming solution through aseptic filtration. This invention provides a method for sterilizing an ophthalmic composition that includes timolol or its salts, along with pharmaceutically acceptable agents. The sterilization is achieved using an aseptic filtration technique, which optimizes process parameters by varying heating time to control the viscosity of the composition. The filtration is conducted under aseptic conditions using a 0.45 μm clarification pre-filter followed by a 0.2 μm sterilizing grade filter. This process is noted for being simple and economical.

Career Highlights

Mallinath Harwalkar is currently associated with Sentiss Pharma Private Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the field of ophthalmic solutions, ensuring that patients receive safe and effective treatments.

Collaborations

Mallinath has collaborated with several professionals in his field, including Manish Kumar Singh and Sai Kiran Jana. These collaborations have further enhanced the development and implementation of his innovative solutions.

Conclusion

Mallinath Harwalkar's contributions to the field of ophthalmic compositions through his patented sterilization process exemplify his dedication to innovation in pharmaceuticals. His work not only improves product safety but also enhances the overall quality of healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…